Ypsomed Holding AG (XSWX:YPSN) Beta: 0.8845 (As of Jun. 24, 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
91 GF Score
Price CHF353.00
GF Value CHF397.52
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Beta?

Ypsomed Holding AG XSWX:YPSN +1.91% 91 Beta is 0.8845 as of Jun. 24, 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.52 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Ypsomed Holding AG's Beta is 0.8845.


Ypsomed Holding AG  (XSWX:YPSN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Ypsomed Holding AG Beta Related Terms


Ypsomed Holding AG Beta Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Beta Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.29 1.03 1.47 0.69

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.47 1.47 1.64 0.69

XSWX:YPSN vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Beta distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Beta falls into.


XSWX:YPSN
91GF Score
Ypsomed Holding AG XSWX:YPSN
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8845 mean?
Ypsomed Holding AG (XSWX:YPSN) has a Beta of 0.8845 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's Beta too high?
Ypsomed Holding AG's current Beta is 0.8845. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Beta compare to ISRG and BDX?
Ypsomed Holding AG's Beta of 0.8845 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Beta is 0.8845. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.52, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current Beta is 0.8845. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Beta is 0.8845 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.52. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

  • Beta: 0.8845
  • GF Value™: CHF397.52 vs. price of CHF353.00 (11.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score

Get the complete analysis for XSWX:YPSN

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF353.00
Price
CHF397.52
GF Value